|
GenScript corporation
full-length human runx1b complementary dnas Full Length Human Runx1b Complementary Dnas, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+complementary+dnas/pm20206228-66-0-14?v=GenScript+corporation Average 90 stars, based on 1 article reviews
full-length human runx1b complementary dnas - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
BioChain Institute
complementary dnas for human mus81, eme1 and fanca ![]() Complementary Dnas For Human Mus81, Eme1 And Fanca, supplied by BioChain Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+complementary+dnas/pmc03919598-32-7-21?v=BioChain+Institute Average 90 stars, based on 1 article reviews
complementary dnas for human mus81, eme1 and fanca - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
GenScript corporation
human cx31.9 wild-type (wt), np_689343.3:p.(his175tyr) np_689343.3:p.(arg253pro) complementary dnas ![]() Human Cx31.9 Wild Type (Wt), Np 689343.3:P.(His175tyr) Np 689343.3:P.(Arg253pro) Complementary Dnas, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+complementary+dnas/pmc11737067-133-4-45?v=GenScript+corporation Average 90 stars, based on 1 article reviews
human cx31.9 wild-type (wt), np_689343.3:p.(his175tyr) np_689343.3:p.(arg253pro) complementary dnas - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
LeukoSite Inc
human complementary dnas (cdnas) for has1 ![]() Human Complementary Dnas (Cdnas) For Has1, supplied by LeukoSite Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+complementary+dnas/pm10566653-76-5-15?v=LeukoSite+Inc Average 90 stars, based on 1 article reviews
human complementary dnas (cdnas) for has1 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Maxim Biotech Inc
complementary dnas encoding full sequences of human pc2 ![]() Complementary Dnas Encoding Full Sequences Of Human Pc2, supplied by Maxim Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+complementary+dnas/pm19628676-36-24-34?v=Maxim+Biotech+Inc Average 90 stars, based on 1 article reviews
complementary dnas encoding full sequences of human pc2 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Nucleic Acids Research
Article Title: Damage-dependent regulation of MUS81-EME1 by Fanconi anemia complementation group A protein
doi: 10.1093/nar/gkt975
Figure Lengend Snippet: Interaction of FANCA and MUS81 on ICL damage in living cells. ( A ) Western blot of FANCA knockdown. U2OS cells were transfected with an ON-TARGET Plus SMART Pool siFANCA, a control siRNA (siCtrl), and dH 2 O (Mock) through lipofectamine. Forty-eight hours later, 50 µg of whole cell protein extract was prepared for western blot analysis using a FANCA-specific antibody. Actin is the loading control. ( B ) U2OS cells were transfected with GFP-FANCA and treated with 8-MOP and/or a 405 nm laser beam as indicated. Laser passing path is indicated by yellow arrows. The panel is representative of 25 examined nuclei of each treatment. 25/25 showed the laser-induced FANCA stripes in the presence of 8-MOP. ( C ) Mock, control siRNA and siFANCA treated U2OS cells were transfected with GFP-MUS81 and treated with 8-MOP and/or a 405 nm laser beam as indicated. Laser passing path is indicated by yellow arrows. The panel is representative of 25 examined nuclei of each treatment. 25/25 showed the laser-induced MUS81 stripes in the presence of 8-MOP for the mock and control treatment. 25/25 of siFANCA nuclei did not show the laser-induced MUS81 stripes in the presence of 8-MOP.
Article Snippet: Complementary DNAs for human MUS81, EME1 and
Techniques: Western Blot, Knockdown, Transfection, Control
Journal: Nucleic Acids Research
Article Title: Damage-dependent regulation of MUS81-EME1 by Fanconi anemia complementation group A protein
doi: 10.1093/nar/gkt975
Figure Lengend Snippet: Effect of FANCA on MUS81-EME1-mediated DNA incision. ( A ) Undamaged and psoralen ICL-damaged substrates were incubated with 1.5 nM of MUS81-EME1, respectively, and an increasing concentration of FANCA (0, 1.25, 2.5, 5, 10, 15 and 20 nM). DNA markers are shown in nucleotide on the left. Same marker as described in was used. ( B ) Quantitation of three independent experiments. MUS81-EME1 activity was calculated as percentage of incision products out of the input substrates. The experiment without FANCA was normalized to 0 and used to calibrate all other experiments with the indicated amount of FANCA. Error bars: standard deviation. Dashed line: Phase I and Phase II border. ( C ) Fold changes of the MUS81-EME1 regulation by FANCA. The experiment without FANCA was arbitrarily normalized to 0 for fold change and used to calibrate all other experiments with the indicated amount of FANCA. Error bars: standard deviation. Psoralen mono-adducted ( D ) and a benzo(α)pyrene diolepoxide deoxyguanosine adducted 3′ ssDNA branch structures ( E ) were incubated with 1.5 nM of MUS81-EME1 and an increasing concentration of FANCA (0, 1.25, 2.5, 5, 10, 15 and 20 nM). The schematic appearance of the products after incision are shown on the right. Letter P with a circle indicates 5′- 32 P labeling.
Article Snippet: Complementary DNAs for human MUS81, EME1 and
Techniques: Incubation, Concentration Assay, Marker, Quantitation Assay, Activity Assay, Standard Deviation, Labeling
Journal: Nucleic Acids Research
Article Title: Damage-dependent regulation of MUS81-EME1 by Fanconi anemia complementation group A protein
doi: 10.1093/nar/gkt975
Figure Lengend Snippet: Effect of FANCA mutants on MUS81-EME1-mediated DNA incision. ( A ) Psoralen ICL-damaged (top) and ICL-undamaged DNA substrates (bottom panel) were incubated with 1.5 nM of MUS81-EME1 and 20 nM of purified WT and mutant FANCA proteins as indicated. DNA markers are shown on the left. The schematic appearance of the products after incision are shown on the right. Letter P with a circle indicates 5′- 32 P labeling. Asterisk indicates a decayed and uncross-linked species. ( B ) Quantitation of three independent experiments. Incision efficiency was normalized to WT-FANCA (arbitrarily assigned as 100%). Error bars: standard deviation. ( C ) Ability to discriminate ICL from undamaged DNA by FANCA mutants. The discrimination factor was calculated by dividing the relative incision rate of ICL of a protein in (B) by the relative incision rate of undamaged DNA of the same protein. The discrimination factor for FANCA was arbitrarily assigned as 100%.
Article Snippet: Complementary DNAs for human MUS81, EME1 and
Techniques: Incubation, Purification, Mutagenesis, Labeling, Quantitation Assay, Standard Deviation
Journal: Nucleic Acids Research
Article Title: Damage-dependent regulation of MUS81-EME1 by Fanconi anemia complementation group A protein
doi: 10.1093/nar/gkt975
Figure Lengend Snippet: A working model for the regulation of MUS81-EME1 activity by FANCA. Blockage of DNA replication forks by an unknown damage (black box and question mark) initiates recruitment of FANCA (blue oval). FANCA recognizes ICL damage (red zigzag) and subsequently recruits MUS81-EME1 to incise the leading strand at the 5′ side of the ICL. If the damage only affects one DNA strand (green block) or there is no damage, FANCA will inactivate MUS81-EME1 to prevent unnecessary incisions. Red arrow: DNA incision; red cross: inactivation.
Article Snippet: Complementary DNAs for human MUS81, EME1 and
Techniques: Activity Assay, Blocking Assay